Canaccord Genuity Starts Rigel Pharmaceuticals (RIGL) at Hold
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $42.58 +4.39%
Rating Summary:
5 Buy, 8 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
5 Buy, 8 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Canaccord Genuity initiates coverage on Rigel Pharmaceuticals (NASDAQ: RIGL) with a Hold. PT $8.00.
For an analyst ratings summary and ratings history on Rigel Pharmaceuticals click here. For more ratings news on Rigel Pharmaceuticals click here.
Shares of Rigel Pharmaceuticals closed at $8.32 yesterday.
For an analyst ratings summary and ratings history on Rigel Pharmaceuticals click here. For more ratings news on Rigel Pharmaceuticals click here.
Shares of Rigel Pharmaceuticals closed at $8.32 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rigel launches breast cancer drug Veppanu at $29,400 per month
- Rigel Announces Availability of VEPPANU™ (vepdegestrant) for Patients with ER+/HER2-, ESR1-Mutated Advanced or Metastatic Breast Cancer
- Oppenheimer Starts Carriage Services (CSV) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
